Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs9349238 | chr6:42663548 | G/C | 2.89E-8 | 133 | 37.95 | 47.52 | 20.6 | KM Plot |
| TGCT | rs9357400 | chr6:42591128 | G/A | 2.74E-8 | 133 | 37.95 | 50.8 | 20.6 | KM Plot |
| TGCT | rs9358856 | chr6:25426768 | C/T | 2.4E-6 | 134 | 49.93 | 32.37 | 18.93 | KM Plot |
| TGCT | rs9367157 | chr6:42591285 | G/A | 2.74E-8 | 133 | 37.95 | 50.8 | 20.6 | KM Plot |
| TGCT | rs9367160 | chr6:42618490 | C/T | 2.46E-8 | 134 | 37.62 | 51.67 | 20.6 | KM Plot |
| TGCT | rs9367161 | chr6:42653359 | C/T | 4.0E-8 | 131 | 37.62 | 47.52 | 20.6 | KM Plot |
| TGCT | rs9369372 | chr6:42575703 | T/C | 2.74E-8 | 133 | 20.6 | 51.67 | 37.7 | KM Plot |
| TGCT | rs9369373 | chr6:42575723 | G/T | 2.74E-8 | 133 | 20.6 | 51.67 | 37.7 | KM Plot |
| TGCT | rs938044 | chr15:48034357 | A/G | 9.68E-6 | 134 | 16.53 | 41.42 | 45.1 | KM Plot |
| TGCT | rs9381203 | chr6:42583625 | G/A | 3.23E-8 | 132 | 37.7 | 50.8 | 20.6 | KM Plot |
| TGCT | rs9381211 | chr6:42670374 | G/A | 4.33E-6 | 128 | 41.97 | 49.93 | 23.82 | KM Plot |
| TGCT | rs9394910 | chr6:42555254 | T/C | 3.69E-9 | 131 | 19.33 | 51.67 | 37.95 | KM Plot |
| TGCT | rs9394911 | chr6:42562996 | T/C | 5.32E-9 | 128 | 19.33 | 52.38 | 37.95 | KM Plot |
| TGCT | rs9394913 | chr6:42632246 | G/A | 2.46E-8 | 134 | 37.62 | 51.67 | 20.6 | KM Plot |
| TGCT | rs9394917 | chr6:42660017 | A/G | 4.0E-8 | 131 | 37.62 | 47.52 | 20.6 | KM Plot |